Earnings Analysis

Not Yet In Escape Orbit But No Hydrazine Leaks Either

When Deleverage Is A Good Thing

DISCLAIMER: This note is intended for US recipients only and,

ABNB posted a decent Q2 FY12/2024; however, the TTM revenue growth declined to 16%. Management provided weak guidance for Q3 FY12/2024, attributed to slowing demand from US guests. The stock fell a solid 14% post-earnings and found support at, wait for it, the c-wave = 1.618 * a-wave level.

Apparently toast in real life; but rather promising on a stock chart.

Thank U, Next

Nobody Mention Blue Screen Day. On Pain Of Death!

CRWD’s Loss Is S’s Gain

Not So Difficult Really.

Looooong in the tooth.